Posted inInfections, New Drugs, Regulatory Vivjoa: First Drug for Chronic Vaginal Yeast Infection Oteseconazole by Mycovia Pharmaceuticals will prevent the risk of recurrent episodes of vulvovaginal candidiasis.
